PRESS RELEASE published on 02/06/2024 at 16:00, 2 years 1 month ago PRODIGY BIOTECH ENTERS INTO A PARTNERSHIP AGREEMENT WITH LEADING CANCER CENTER TO ADVANCE PRODUCTS TO IMPROVE OUTCOMES IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Prodigy Biotech partners with leading cancer center MSK to develop products improving outcomes in patients undergoing allogenic hematopoietic stem cell transplantation. The collaboration aims to evaluate a product targeting Enterococcus sp. to treat microbial dysbiosis and reset the gut microbiome, potentially mitigating disease severity Prodigy Biotech MSK Cancer Center Allogenic Hematopoietic Stem Cell Transplantation Microbial Dysbiosis
Published on 03/26/2026 at 12:59, 3 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 17 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 12:45, 17 minutes ago Electric Royalties Provides Update on Critical Metals Royalty Portfolio
Published on 03/26/2026 at 12:30, 32 minutes ago Nextech3D.ai Expands Blockchain Ticketing Payments to Apple Pay and Google Pay, Advancing Platform Readiness for Adoption
Published on 03/26/2026 at 12:45, 17 minutes ago Original-Research: CLINUVEL Pharmaceuticals Limited (von Parmantier & Cie. GmbH): Buy
Published on 03/26/2026 at 12:20, 41 minutes ago North Peak Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement, Raising Total Funds of $5.675 Million
Published on 03/26/2026 at 12:17, 45 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 03/26/2026 at 12:05, 57 minutes ago Artlist Expands Its AI Platform with Professional-Grade AI Music for Video Production
Published on 03/26/2026 at 11:56, 1 hour 6 minutes ago IVU continues its growth trajectory in the 2025 financial year
Published on 03/26/2026 at 07:30, 5 hours 32 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 18 hours 31 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 19 hours 17 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting